Vitamin D supplementation, COVID-19 & Disease Severity: A meta-analysis
QJM . 2021 Jan 24;hcab009. doi: 10.1093/qjmed/hcab009
Komal Shah 1, Deepak Saxena 1, Dileep Mavalankar 1
Study from indian focused on Icu and mortality - discussion is at the bottom of this page
 Download the PDF from Vitamin D Life
Virus meta-analyses
- COVID and Vitamin D: 2X more likely to die if low, 2X more likely to survive if supplement – umbrella meta-analysis April 2024
- COVID fought by Vitamin D: 2.3X less likely to die of COVID if supplemented, 1.9 X less likely to become infected – meta-analysis March 2024
- COVID Vaccinations increased risk of cardiac deaths in youths by 19% - Aug 2023
- T1 Diabetes increased by 27% by second year of COVID – meta-analysis June 2023
- Yet another reason to take Vitamin D while pregnant – fight COVID - meta-analysis May 2023
- COVID death 1.5 X less likely if high vitamin D, emergency D (50K to 100K) is great – meta-analysis March 2023
- COVID ICU 3X less-likely if take any amount and type of Vitamin D – meta-analysis Jan 2023
- COVID and Vitamin D: any amount of D, at any time, for any duration reduced ICU - meta-analysis Dec 2022
- Worse COVID during 3Q pregnancy if 2.5 ng lower Vitamin D – meta-analysis Sept 2022
- Severe COVID 2.6 X less likely if supplement with Vitamin D – 26th meta-analysis - July 2022
- COVID Long-Haul prevalence increases with time: 50% at 4 months - meta June 2022
- COVID test positive is about half as likely if have Vitamin D – 24th meta-analysis - Jan 2022
- Small amounts of Vitamin D reduce Influenza risk by 22 percent (loading dose is far better) – meta-analysis Jan 2022
- Vitamin D fights COVID (54 studies of 1,400,000 people) – 23rd meta-analysis - Dec 2021
- COVID-19 treated by Vitamin D (reduce ICU by 3X) - 22nd meta-analysis - Dec 29, 2021
- COVID-19 death increased 2X if low Vitamin D (less than 10 to less than 30 ng) – 21st meta-analysis Dec 2021
- COVID-19 risk reduced by vitamin D supplementation – umbrella review of 7 meta-analysis – Oct 2021
- COVID-19 treated by Vitamin D (example: ICU reduced by 5X) – 20th meta-analysis Oct 13, 2021
- Severe COVID-19 2.5 X more likely if low vitamin D (23 studies) – 19th meta-analysis Oct 2021
- COVID-19 mortality extrapolates to zero at 50 ng of vitamin D – 18th Meta-analysis Sept 2021
- COVID-19 death 1.6 X more likely if low vitamin D (24 studies) – 17th meta-analysis Aug 2021
- Severe COVID-19 5X more likely if low vitamin D (23 studies) – 16th meta-analysis July 2021
- Severe COVID-19 3.5 more likely if low vitamin D (30 studies) – meta-analysis July 2021
- COVID-19 patients who had supplemented with Vitamin D were 3X less likely to enter ICU – June 2021
- Low Calcium associated with severe COVID-19 – several studies
- COVID-19 mortality 3X more likely if low vitamin D (999,179 people) – meta-analysis March 29, 2021
- COVID-19 was 2.6X more severe if very low Vitamin D (43 studies) – meta-analysis March 26, 2021
- Low Vitamin D associated with 2.7X more severe COVID-19 – 12th MA March 5, 2021
- Vitamin D supplementation fights COVID-19 – 11th meta-analysis Jan 24, 2021
- 3.7 X less likely to die of COVID-19 if supplemented with Vitamin D - meta-analysis Jan 5, 2021
- Less likely to test positive for COVID-19 if higher Vitamin D – meta-analysis Jan 6, 2021
- Vitamin D reduces COVID-19 by 80 percent - anonymous meta-analysis - Jan 5, 2021
- COVID-19 1.7X more likely to be severe if low Vitamin D - meta-analysis Oct 2020
- Low Vitamin D associated 1.8X increased risk of COVID-19 death in hospital – meta-analysis Nov 4, 2020
- Acute viral respiratory infections (RTI) reduced by Vitamin D - 20 reviews - Aug 2020
- Prudent to consider that Vitamin D has a role in COVID-19 – meta-analysis – Aug 7, 2020
- Risk of enveloped virus infection is increased 50 percent if poor Vitamin D Receptor - meta-analysis Dec 2018
- Hepatitis B patients have 2 ng lower level of Vitamin D – meta-analysis June 2019
- Influenza Vaccination not benefited by lowish levels of vitamin D – meta-analysis March 2018
Mortality and Virus studies
- COVID and Vitamin D: 2X more likely to die if low, 2X more likely to survive if supplement – umbrella meta-analysis April 2024
- Moderna report: their COVID vax caused "only" 17,751 deaths - April 2024
- COVID infection (without hospitalization) – 1.7X more likely to die in 6 months if low Vitamin D – March 2024
- Vaccines increased your risk of dying of COVID in NZ - official data - Feb 2024
- 3X increase in unspecified causes of Death (Canada 2019-2022) - Dec 2023
- Deaths after vaccination - also reported in Japan - Dec 2023
- Excess deaths after COVID vaccination - 17 countries - Sept 2023
- Excess Deaths in Australia jumped up in 2022– preprint Feb 2023
- Prevent a COVID death: 9 dollars of Vitamin D or 900,000 dollars of vaccine - Aug 2023
- Number needed to vaccinate to prevent 1 Omicron death: 30,000 for age 60-70 - Sept 2022
- COVID survival in Europe in 2020 best predicted by population-level Vitamin D (of 13 variables) – July 2022
- Elderly who had been in COVID ICU were 4X more likely to die if low vitamin D – Nov 2022
- More COVID mortality if less than 20 ng of Vitamin D (Mexico) – May 2022
- 15,000,000 excess deaths in 2 years - May 2022
- COVID death 5.2X more likely if Vitamin D deficient – May 2022
- 29 X more likely to die of COVID if less than 20 ng of Vitamin D - March 2022
- Giving Vitamin D reduced COVID Mortality– Review of 11 studies – March 2022
- 18 million excess global deaths in past 2 years: COVID plus collateral damage - Lancet March 2022
- COVID severity and death more likely if low vitamin D (Egypt this time) - March 2022
- US nursing homes are epicenters for COVID deaths (200,000) - Feb 2022
- Ivermectin taken before COVID decreased death rate by 68 percent (3,000 with Ivermectin vs 3,000 without) - Dec 24, 2021
- Increase in non-COVID deaths (ages 18-64) in Indiana, India, etc. - Jan 5, 2022
- Only 35,000 died in US of COVID who previously had been healthy
- COVID-19 mortality extrapolates to zero at 50 ng of vitamin D – 18th Meta-analysis Sept 2021
- COVID-19 patients getting 300,000 IU of Vitamin D were 5X less likely to die – Sept 2021
- Predict 2X more likely to die of COVID-19 if vitamin D Deficient (Iran 2020) – Sept 2021
- COVID-19 mortality not associated with Vitamin D (everyone had very low levels) -Sept 2021
- COVID-19 mortality for Blacks is 5X that for whites in 2 LA Hospitals - July 2021
- COVID-19 mortality was associated with vitamin D deficiency of 47 countries – July 2021
- Similar death rate for Vaccination and COVID-19 study and video – June 24, 2021
- COVID-19 death in hospital 5X more likely if low vs high vitamin D – preprint June 2021
- COVID-19 deaths 1.7X more likely if low vitamin D (even after “adjusting” for low D health problems) – May 2021
- COVID-19 deaths 1.5X less likely if more than 40 ng of vitamin D – US VA – April 2021
- Vitamin D supplementation and high levels reduce COVID-19 deaths in elderly – Review April 17, 2021
- Less COVID-19 infection, mortality in countries with higher Vitamin D (Asia in this case) – May 2021
- COVID-19 was the third-leading cause of death in the US, especially in those with dark skins - April 1, 2021
- Risk of COVID-19 death was 4.9 X higher if very low vitamin D – March 31, 2021
- COVID-19 mortality 2X higher if low Vitamin D (Mexican hospital, preprint) - March 2021
- All COVID-19 patients had low vitamin D, the lowest were more likely to die – Feb 18, 2021
- 2.7 fewer COVID-19 hospital deaths in those having more than 30 ng of vitamin D – Mayo Jan 9, 2021
- Worse COVID-19 patients got 400,000 IU of vitamin D, deaths cut in half – Jan 14, 2021
- Iranians with COVID-19 were 2.3 X more likely to die if low vitamin D – Jan 2021
- Poor COVID-19 prognosis was 6 X more likely if low vitamin D – Jan 21, 2021
- Less than 10 dollars of Vitamin D per COVID-19 life saved in Myanmar - Jan 2021
- 2.8 X fewer COVID-19 nursing home deaths if add 10,000 IU Vitamin D daily for a week (small observation)- Jan 2021
- Italian nursing home COVID-19 – 4X less likely to die if taking Vitamin D– Dec 22, 2020
- Shift workers 2X more likely to get COVID-19 (low Vitamin D) - Dec 2020
- Those getting high dose vitamin D were 7 X less likely to die of COVID-19 - Dec 11, 2020
- COVID-19 male mortality increased 3.9 X if low vitamin D – observation Nov 25, 2020
- Hospital COVID-19 observation: 7X more likely to live if more than 20 ng of vitamin D– Nov 19, 2020
COVID-19 treated by Vitamin D - studies, reports, videos
As of March 31, 2024, the Vitamin D Life COVID page had: trial results, meta-analyses and reviews, Mortality studies see related: Governments, HealthProblems, Hospitals, Dark Skins, All 26 COVID risk factors are associated with low Vit D, Fight COVID-19 with 50K Vit D weekly Vaccines Take lots of Vitamin D at first signs of COVID 166 COVID Clinical Trials using Vitamin D (Aug 2023) Prevent a COVID death: 9 dollars of Vitamin D or 900,000 dollars of vaccine - Aug 2023
5 most-recently changed Virus entries
Discussion:
To the best of our knowledge this is the first meta-analysis that synthesized cumulative evidences assessing impact of vitamin D supplementation on intensive care needs and mortality in hospitalized COVID-19 patients. It was observed that as compared to conventional care, vitamin D reduces severity of the disease; however, the results regarding improving mortality statistics could not reach to a statistically significant conclusion.
#1
The first study conducted by Castillo et al.16 randomized 76-consecutive hospitalized COVID-19 patients in intervention to control group in ratio of 2:1 in Spain. The patients in the intervention arm received soft capsules of calcifediol (0.532 mg) on the day of admission through oral route and continued with the oral calcifediol (0.266 mg) on day 3, 7, and then weekly until discharge or ICU admission. Whereas the patients in the control arm followed the standard treatment protocol with combination of hydroxychloroquine (400 mg every 12 h on the first day, and 200 mg every 12 h for the following 5 days), azithromycin (500 mg orally for 5 days). Though baseline characteristics of patients in both the arms were matched, controls were more hypertensive (57.69% vs 24.19%; p=0.002). To adjust the effect of the confounders such as hypertension and diabetes, authors applied multivariate logistic regression analysis and found that the lower probability of ICU admission in intervention still remained significant odds ratio=0.03 (95 % CI: 0.003- 0.25) as compared to control. Similarly, the mortality rates were also lower in patients treated with calciferol, however it could not reach to a statistically significant level possibly due to extremely lower number of patients with adverse outcome. However, authors also acknowledged potential confounding effect of obesity and pre-existing deficiency of vitamin D as limitation of study. They recommended need of more extensive research with appropriately matched arms.
#2
A double-blind, randomized, placebo-controlled trial in Brazil conducted by Murai et al.,17 showed an effect of a single dose of 200,000 IU of vitamin D3 supplementation to hospital stay in severely ill COVID-19 patients. During the trial, 240 patients were equally randomized either in vitamin D supplementation or placebo arm. The baseline demographic and clinical characteristics were comparable between both the arms. Though the supplementation was found to be safe and it improved serum 25-hydroxyvitamin D levels, it did not translate into any clinical benefits to the patient in the form of reduced hospital stay, the requirement of ICU support or mortality rate. Hence the authors recommended against the use of vitamin D as adjuvant therapy in hospitalized COVID patients. Though it was found that requirement of oxygen therapy was low in patients treated with vitamin D as compared to placebo group (65.5% vs 85.9%; p=0.008). Removal of this study from overall analysis resulted in lowering of heterogeneity in cumulative findings of metaanalysis and yielded beneficiary effect on ICU needs with vitamin D.
#3
Hernandez et al.,18 retrospectively assessed the role of vitamin D supplementation on 216 hospitalized COVID-19 positive patients in Spain. It was observed that 19 patients who were on vitamin D supplementation, had drastically low requirement of ICU care as compared to their counterparts (5.3% vs 25.4%), however similar to other studies there was no difference in mortality (10.5% vs 10.4%) between both the groups. The study also compared the serum levels of 25- hydroxyvitamin D in hospitalized COVID patients and compared it with the population-based controls of similar age and sex. It was found the patients had significantly low levels of serum 25- hydroxyvitamin D as compared to population based-controls even in the presence of main confounding factors. However, the observational nature of the study was accepted as one of the important limitations. One important finding emerged from the study was that unlike other reports there was no relationship between serum 25-hydroxyvitamin D levels and the parameters of COVID-19 severity, such as ICU admission, the need for mechanical ventilation, or mortality. This might be due to smaller number of events in the groups. However, it also highlights the need to assess Vit D supplementation's effect in a prospective manner using the randomized controlled trial study design.
#4
SHADE study19, a randomized controlled trial assessed effect of high-dose vitamin D supplementation (60 000 IU of cholecalciferol - oral nano-liquid droplets) on 21-days recovery in COVID-19 patients. The authors found that greater proportion of vitamin D-deficient individuals with SARS-CoV-2 infection turned COVID-19 negative with a significant decrease in fibrinogen on high-dose cholecalciferol supplementation. However, they did not assess the role of supplementation on ICU requirement and mortality and hence were not included in the current meta-analysis.
Despite this heterogeneity among the studies, cumulative findings of the meta-analysis favored vitamin D supplementation for reduction of COVID-19 severity. However, more trials are required to substantiate the findings on other outcomes, especially community based and in-hospital trials should also be conducted in developing countries to assess potential of vitamin D supplementation in reducing hospitalization-, ICU- and ventilation needs and mortality rates.